Latest / Cell & Gene: The Podcast

Redefining CAR-T Timing and Patient Access with Allogene Therapeutics' Dr. Zachary Roberts
We love to hear from our listeners. Send us a message.
In episode 129 of Cell & Gene: The Podcast, Host Erin Harris reconnects with Zachary Roberts, M.D., Ph.D., EVP of Research & Development and Chief Medical Officer at Allogene Therapeutics, to explore how allogeneic CAR-T is evolving from a scalability promise into an earlier-line, potentially curative intervention. Their conversation centers on the ALPHA3 trial, where MRD-guided treatment is redefining when and how CAR-T can be deployed, alongside broader implications for diagnostics, patient access, and the shift toward off-the-shelf…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.